Effectiveness of bronchodilators in cystic fibrosis

American Journal of Medicine

Volumn 100, Issue 1 A, 1996, Pages S19-S29

  Cropp, G J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPHYLLINE; ATROPINE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; FENOTEROL; HISTAMINE; IPRATROPIUM BROMIDE; ISOPRENALINE; METHACHOLINE; ORCIPRENALINE; SALBUTAMOL; TERBUTALINE; THEOPHYLLINE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT;

AEROSOL; AIRWAY OBSTRUCTION; BRONCHUS HYPERREACTIVITY; CONFERENCE PAPER; CYSTIC FIBROSIS; DISEASE COURSE; DRUG ADMINISTRATION; DRUG EFFICACY; EXPIRATORY FLOW RATE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROVOCATION TEST; DRUG EFFECT; INHALATION TEST; LUNG FUNCTION TEST; LUNG VENTILATION; PATHOPHYSIOLOGY; REVIEW;

ADRENERGIC BETA-AGONISTS; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; BRONCHODILATOR AGENTS; CYSTIC FIBROSIS; DISEASE PROGRESSION; HUMANS; IPRATROPIUM; PARASYMPATHOLYTICS; PULMONARY VENTILATION; RESPIRATORY FUNCTION TESTS;

EID: 84882554669     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9343(96)80049-0     Document Type: Conference Paper

References (38)

1. Ferguson G.T. Cherniack R.M. Management of chronic obstructive pulmonary disease N Engl J Med. 328 1993 1017 1022
2. Gross N.J. Drug therapy: ipratropium bromide N Engl J Med. 319 1988 486 494
3. Hargreave F.L. Thomson N.C. O'Byrne P.M. Bronchial responsiveness to histamine or methacholine in asthma: measurement and clinical significance J Allergy Clin Immunol. 63 1981 347 355
4. Yan K. Salome C.M. Woolcock A.J. Rapid method for measurement of bronchial hyperresponsiveness Thorax 45 1990 860 865
5. Van Asperen P. Mellis C.M. South R.T. Simpson S.J. Bronchial reactivity in cystic fibrosis with normal pulmonary function Am J Dis Child. 135 1981 815 819
6. Mellis C.M. Levison H. Bronchial reactivity in cystic fibrosis Pediatrics 61 1978 446 450
7. Mitchell I. Corey M. Woenne R. Bronchial hyperreactivity in cystic fibrosis and asthma J Pediatr. 93 1978 744 748
8. Tobin M.J. Maguire 0. Reen D. Atopy and bronchial reactivity in older patients with cystic fibrosis Thorax 35 1980 807 813
9. Ackerman V. Montgomery G. Eigen H. Tepper R.S. Assessment of airway responsiveness in infants with cystic fibrosis Am Rev Resp Dis. 144 1991 344 346
10. Burdon J.G.W. Cade J.F. Sutherland P.W. Pain M.C.F. Cystic fibrosis and bronchial hyperreactivity Med J Aust. 2 1980 77 78
11. Eggleston P.A. Rosenstein B.J. Stackhouse C.M. A controlled trial of longterm bronchodilator therapy in cystic fibrosis Chest 99 1991 1088 1092
12. van Haren E.H.J. Lammers J.W. Festen J. van Herwaarden C.L.A. Bronchial vagal tone and responsiveness to histamine, exercise and bronchodilators in adult patients with cystic fibrosis Eur Respir J. 5 1992 1083 1088
13. Sanchez I. Powell R.E. Chernick V. Response to inhaled bronchodilators and nonspecific airway hyperreactivity in children with cystic fibrosis Pediatr Pulmonol. 14 1992 52 57
14. Avital A. Sanchez I. Chernick V. Efficacy of salbutamol and ipratropium bromide in decreasing bronchial hyperreactivity in children with cystic fibrosis Pediatr Pulmonol. 13 1992 34 37
15. Larsen G.L. Barron R.J. Landay R.A. Cotton E.K. Intravenous aminophylline in patients with cystic fibrosis Am J Dis Child. 134 1980 1143 1148
16. Pan S.H. Canafax D.M. Le C.T. Bronchodilation from intravenous theophylline in patients with cystic fibrosis: results of a blinded placebo-controlled crossover clinical trial Pediatr Pulmonol. 6 1989 172 179
17. 2 in children with cystic fibrosis Am Rev Respir Dis. 144 1991 1245 1249
18. Finnegan M.J. Hughes D.V. Hodson M.E. Comparison of nebulized and intravenous terbutaline during exacerbations of pulmonary infection in patients with cystic fibrosis Eur Respir J. 5 1992 1089 1091
19. Featherby E.A. Weng T.R. Levison H. The effect of isoproterenol on airway obstruction in cystic fibrosis Can Med Assoc J. 102 1970 835 838
20. Landau L.I. Phelan P.D. The variable effect of a bronchodilating agent on pulmonary function in cystic fibrosis J Pediatr. 82 1973 863 868
21. Larsen G.L. Barron R.J. Cotton E.K. Brooks J.I.G. A comparative study of inhaled atropine sulphate and isoproterenol hydrochloride in cystic fibrosis Am Rev Respir Dis. 119 1979 399 407
22. Kattan M. Mansell A. Levison H. Response to aerosol salbutamol, SCH 1000, and placebo in cystic fibrosis Thorax 35 1980 531 535
23. Zach M.S. Oberwaldner B. Forche G. Polgar G. Bronchodilators increase airway instability in cystic fibrosis Am Rev Respir Dis. 131 1985 537 543
24. Hiatt P. Eigen H. Yu P. Tepper R.S. Bronchodilator responsiveness in infants and young children with cystic fibrosis Am Rev Respir Dis. 137 1988 119 122
25. Maayan C.H. Bar-Yishay E. Yaacobi T. Immediate effects of various treatments on lung function in infants with cystic fibrosis Respiration 55 1989 144 151
26. Weintraub S.J. Eschenbacher W.L. The inhaled bronchodilators ipratropium bromide and metaproterenol in adults with cystic fibrosis Chest 95 1989 861 864
27. Macfarlane P.I. Heaf D. Changes in airflow obstruction and oxygen saturation in response to exercise and bronchodilators in cystic fibrosis Pediatr Pulmonol 8 1990 4 11
28. Pattishall E.N. Longitudinal response of pulmonary function to bronchodilators in cystic fibrosis Pediatr Pulmonol 9 1990 80 85
29. van Haren E.H.J. Lammers J.W.J. Festen J. van Herwaarden C.L.A. Bronchodilator response in adult patients with cystic fibrosis: effects on large and small airways Eur Respir J. 4 1991 301 307
30. Hordvik N.L. Konig P. Morris D. A longitudinal study of bronchodilator responsiveness in cystic fibrosis Am Rev Respir Dis. 131 1985 889 893
31. Regelmann W.E. Elliott G.R. Warwick W.J. Clawson C.C. Reduction of sputum Pseudomonas aeruginosa density by antibiotics improves lung function in cystic fibrosis more than do bronchodilators and chest physiotherapy alone Am Rev Respir Dis 141 1990 914 921
32. Zinman R. Wohl M.E.B. Ingram R.H. Jr Nonhomogeneous lung emptying in patients with cystic fibrosis Am Rev Respir Dis 143 1991 1257 1261
33. Wood R.E. Wanner A. Hirsch J. Farrell P.M. Tracheal mucociliary transport in patients with cystic fibrosis and its stimulation by terbutaline Am Rev Respir Dis 111 1975 733 738
34. Cloutier M.M. Lesniak K.M. Effects of cAMP, furosemide, and ouabain on transtracheal tetracycline and chloramphenicol influx in the rat Am Rev Respir Dis 129 1984 284 287
35. Cropp G.J.A. The role of the parasympathetic nervous system in the maintenance of chronic airway obstruction in asthmatic children Am Rev Resp Dis 112 1975 599 605
36. Sanchez I. Holbrow J. Chernick V. Acute bronchodilator response to a combination of padrenergic and anticholinergic agents in patients with cystic fibrosis J Pediatr 120 1992 486 488
37. Mulherin D. FitzGerald M.X. Meconium ileus equivalent in association with nebulized ipratropium bromide in cystic fibrosis Lancet 335 1990 552
38. Nickerson B.G. Lemen R.J. Gerdes C.B. Within subject variability and percent change for significance of spirometry in normal subjects and in patients with cystic fibrosis Am Rev Respir Dis 122 1980 859 866